Iridius | $8,600,000 | (Apr 28, 2026)
SquareMind | $18,000,000 | (Apr 28, 2026)
Decade Energy | $25,763,540 | (Apr 28, 2026)
Certified by Founder
Lodge
Fathom Therapeutics
start up
United States
- New York, New York
- 28/04/2026
- Series A
- $47,000,000
We use quantum chemistry and AI to design novel drug molecules by predicting their behavior inside living cells. Reach out to learn more about our Microcosmos drug discovery engine!
- Industry Biotechnology Research
- Website https://www.fathomtx.com/
- LinkedIn https://www.linkedin.com/company/fathomtx/
Linexa | $2,342,840 | (Apr 28, 2026)
HrFlow.ai | $7,000,000 | (Apr 28, 2026)
Zócalo Health | $15,000,000 | (Apr 24, 2026)
VREY | $3,859,432 | (Apr 24, 2026)
QMatter | $1,200,000 | (Apr 24, 2026)
Almanac Health | $10,000,000 | (Apr 24, 2026)
BAND | $17,000,000 | (Apr 24, 2026)